Subgrouped by | No. of studies | OR (95%CI) | I2(%) | P overall effect | P interaction |
---|---|---|---|---|---|
Region | 15 | 1.15(1.07,1.23) | 63.3 | < 0.001 | 0.21 |
Asia | 12 | 1.13(1.05,1.22) | 63.0 | 0.001 | |
Europe | 3 | 1.56(0.95,2.57) | 73.4 | 0.08 | |
Basic illness | 15 | 1.15(1.07,1.23) | 63.3 | < 0.001 | 0.02 |
no | 14 | 1.13(1.06,1.21) | 60.5 | < 0.001 | |
yes | 1 | 2.26(1.24,4.12) | — | 0.008 | |
Cerebrovascular disease | 15 | 1.15(1.07,1.23) | 63.3 | < 0.001 | 0.85 |
stroke | 1 | 1.17(1.06,1.29) | — | 0.001 | |
unclassified | 2 | 1.50(0.78,2.91) | 79.8 | 0.23 | |
cerebral small vessel disease | 2 | 1.19(0.94,1.49) | 66.8 | 0.14 | |
carotid artery disease | 6 | 1.10(0.94,1.29) | 72.9 | 0.24 | |
intracranial arterial disease | 4 | 1.20(1.05,1.37) | 31.8 | 0.006 | |
Sex | 6 | 1.12(1.10,1.24) | 44.4 | 0.03 | 0.39 |
male | 3 | 1.08(0.98,1.19) | 0.0 | 0.12 | |
female | 3 | 1.23 (0.92,1.64) | 77.0 | 0.16 | |
Diabetes | 5 | 1.30(1.05,1.61) | 34.7 | 0.02 | 0.04 |
no | 2 | 1.18(1.03,1.36) | 0.0 | 0.02 | |
yes | 3 | 1.98(1.25,3.14) | 0.0 | 0.004 |